WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)
Pill with imprint WATSON 3359 WATSON 3359 is Pink, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Watson Laboratories, Inc..
Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; nephrotic syndrome; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 3359 WATSON 3359
Tacrolimus
- Imprint:
- WATSON 3359 WATSON 3359
- Strength:
- 5 mg
- Color:
- Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Calcineurin inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- lactose anhydrous
croscarmellose sodium
hypromelloses
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Red No. 40
Note: Inactive ingredients may vary.
More about tacrolimus
- Tacrolimus Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 37 Reviews
- Drug class: calcineurin inhibitors
- FDA Alerts (1)
Consumer resources
- Tacrolimus oral and injection
- Tacrolimus Capsules
- Tacrolimus Extended-Release Capsules
- Tacrolimus Extended-Release Tablets
- Tacrolimus Injection
- ... +2 more
Other brands: Prograf, Astagraf XL, Envarsus XR, Hecoria
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
